Loading...
Docoh

Gene Biotherapeutics (CRXM)

405 filings

Page 2 of 21
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
3
Kaushik K. Vyas
8 Jul 20
Gene Biotherapeutics / Kaushik K. Vyas ownership change
12:37pm
3
Ronald J. Shebuski
8 Jul 20
Gene Biotherapeutics / Ronald J. Shebuski ownership change
12:36pm
3
Nostrum Pharmaceuticals, LLC
1 Jun 20
Initial statement of insider ownership
5:29pm
SC 13D
Nostrum Pharmaceuticals, LLC
1 Jun 20
Gene Biotherapeutics / Nostrum Pharmaceuticals ownership change
5:27pm
8-K
CRXM Gene Biotherapeutics, Inc.
28 May 20
Gene Biotherapeutics Secures Investment from Nostrum Pharmaceuticals, LLC
4:05pm
8-K
CRXM Gene Biotherapeutics, Inc.
20 Mar 19
Gene Biotherapeutics Announces Director Retirement
6:15am
SC 13D
CRXM Gene Biotherapeutics, Inc.
22 Jan 19
Beneficial ownership report
10:05am
NT 10-Q
CRXM Gene Biotherapeutics, Inc.
4 Dec 18
Notice of late quarterly filing
3:16pm
8-K
CRXM Gene Biotherapeutics, Inc.
12 Sep 18
Gene Biotherapeutics Announces Sale of Excellagen Technology
8:00pm
NT 10-Q
CRXM Gene Biotherapeutics, Inc.
16 May 18
Notice of late quarterly filing
4:08pm
8-K
CRXM Gene Biotherapeutics, Inc.
8 Jan 18
Taxus Cardium Announces Name
7:00pm
SC 13G/A
Sabby Management, LLC
3 Jan 18
Taxus Cardium Pharmaceuticals Group Inc.
7:00pm
NT 10-Q
CRXM Gene Biotherapeutics, Inc.
14 Nov 17
Notice of late quarterly filing
7:00pm
NT 10-Q
CRXM Gene Biotherapeutics, Inc.
14 Aug 17
Notice of late quarterly filing
8:00pm
10-Q
2017 Q1
CRXM Gene Biotherapeutics, Inc.
27 Jul 17
Quarterly report
8:00pm
10-K
2016 FY
CRXM Gene Biotherapeutics, Inc.
27 Jul 17
Annual report
8:00pm
NT 10-Q
CRXM Gene Biotherapeutics, Inc.
15 May 17
Notice of late quarterly filing
8:00pm
NT 10-K
CRXM Gene Biotherapeutics, Inc.
29 Mar 17
Notice of late annual filing
8:00pm
10-Q
2016 Q3
CRXM Gene Biotherapeutics, Inc.
20 Mar 17
Quarterly report
8:00pm
10-Q
2016 Q2
CRXM Gene Biotherapeutics, Inc.
5 Mar 17
Quarterly report
7:00pm